Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (361-370 of 632) with videos related to

Pageof 64
Sort By:
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg, Bernd Kronenberger, Holger Hinrichsen, et al.
Lipids in Health and Disease|August 30, 2008
Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liverSimone K Frey, Britta Nagl, Andrea Henze, et al.
Journal of Hepatology|May 22, 2007
A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infectionEckart Schott, Heiko Witt, Konrad Neumann, et al.
BMC Medical Imaging|September 13, 2022
Analysis of patient's X-ray exposure in hepatic chemosaturation procedures: a single center experienceSebastian Ebel, Martin Reinhardt, Anne Bettina Beeskow, et al.
United European Gastroenterology Journal|March 8, 2018
Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world settingChristoph Höner Zu Siederdissen, Peter Buggisch, Klaus Böker, et al.
Scientific Reports|October 28, 2020
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discriminationValentin Blank, David Petroff, Sebastian Beer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 25, 2016
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver diseaseKerstin Herzer, Tania M Welzel, Ulrich Spengler, et al.
Gastroenterology|May 13, 2008
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41Christoph S Klade, Heiner Wedemeyer, Thomas Berg, et al.
Drugs & Aging|August 8, 2018
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C RegistryGeorg Dultz, Tobias Müller, Jörg Petersen, et al.
Pageof 64

Showing results (361-370 of 632) with videos related to

Sort By:
Pageof 64
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg, Bernd Kronenberger, Holger Hinrichsen, et al.
Lipids in Health and Disease|August 30, 2008
Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liverSimone K Frey, Britta Nagl, Andrea Henze, et al.
Journal of Hepatology|May 22, 2007
A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infectionEckart Schott, Heiko Witt, Konrad Neumann, et al.
BMC Medical Imaging|September 13, 2022
Analysis of patient's X-ray exposure in hepatic chemosaturation procedures: a single center experienceSebastian Ebel, Martin Reinhardt, Anne Bettina Beeskow, et al.
United European Gastroenterology Journal|March 8, 2018
Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world settingChristoph Höner Zu Siederdissen, Peter Buggisch, Klaus Böker, et al.
Scientific Reports|October 28, 2020
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discriminationValentin Blank, David Petroff, Sebastian Beer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 25, 2016
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver diseaseKerstin Herzer, Tania M Welzel, Ulrich Spengler, et al.
Gastroenterology|May 13, 2008
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41Christoph S Klade, Heiner Wedemeyer, Thomas Berg, et al.
Drugs & Aging|August 8, 2018
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C RegistryGeorg Dultz, Tobias Müller, Jörg Petersen, et al.
Pageof 64